Immunization Roundup: Updated COVID-19 Vaccines, Mpox Approval, and More
Drug Topics
SEPTEMBER 2, 2024
Catch up on important immunization news from the month of August.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Drug Topics
SEPTEMBER 2, 2024
Catch up on important immunization news from the month of August.
Drug Topics
JULY 31, 2024
Catch up on important immunization news from the month of July.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 17, 2023
At the 44th annual National Association of Pediatric Nurse Practitioners Conference, the CDC provided an updated immunization schedule that details new changes.
Outsourcing Pharma
AUGUST 27, 2024
The INNA-051 formulation is designed to enhance the bodyâs natural immune response, targeting individuals aged 60 and over who are at increased risk for complications from respiratory viral infections.
STAT
JULY 10, 2024
But new research asks the question: What if immune cells could be turned back into good guys, and actually help save tissue damaged by autoimmune disease? Lupus is complicated because it wields the body’s own defenses against itself, generating a continuous immune misfire. Read the rest…
Pharmacy Times
JULY 26, 2024
Study finds traces of “epigenetic scars” on the immune cells of patients who recovered from chronic hepatitis C infection.
Pharmacy Times
AUGUST 26, 2024
Building trust between techs and patients makes administering vaccines easier and increase immunizers’ confidence.
Pharmacy Times
JULY 30, 2024
Immunization rates have not returned to pre-pandemic levels, leaving millions of children and infants at risk for measles or diphtheria, tetanus, and pertussis.
Drug Topics
MAY 21, 2024
Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.
STAT
APRIL 10, 2024
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion, the companies announced Wednesday. It is the largest acquisition in Vertex’s history.
Pharmacy Times
AUGUST 9, 2023
Chad Worz, PharmD, BCGP, FASCP, discusses how vaccine hesitancy and misinformation about flu vaccines create barriers to annual flu immunizations.
Pharmacy Times
AUGUST 16, 2023
Experts discuss the social determinants that can affect the rates of flu immunizations and strategies to boost immunization rates.
Drug Topics
APRIL 9, 2024
Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.
Pharmafile
JULY 30, 2024
Biopharmaceutical company Boehringer Ingelheim has announced the acquisition of drug discovery and development company Nerio Therapeutics for up to $1.3bn, with the aim to develop Nerio’s novel immune checkpoint inhibitors.
Pharmacy Times
JUNE 4, 2024
The immunizing technicians stated they had greater job satisfaction and had a greater sense of being valuable pharmacy members
Pharmacy Times
AUGUST 29, 2024
By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.
pharmaphorum
MAY 22, 2024
Immune checkpoint enhancer biotech AltruBio raises $225m to support phase 2 trials of its PSGL-1-targeted drug for ulcerative colitis
Pharmacy Times
SEPTEMBER 21, 2023
Two separate study findings reported that a subset of dormant CD4+ cells could spontaneously produce HIV RNA and proteins, impacting a patient’s HIV-specific immune responses.
STAT
FEBRUARY 14, 2024
The study , published Wednesday in Nature, underscores the importance of never lighting up that first cigarette, based on its conclusion that smoking has much longer harmful effects on immune responses than previously understood. Read the rest…
Pharmacy Times
JANUARY 2, 2024
The new understanding of immune cells could not only contribute to the development of lung disease treatments, but treatments for other organ systems as well.
STAT
MARCH 27, 2024
Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “ twilight of immunity. ” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.
Pharmacy Times
AUGUST 2, 2023
A panel of experts review the criteria used to select a specific high-dose flu vaccine formulation for immunization.
European Pharmaceutical Review
AUGUST 8, 2024
An investigational, individualised neoantigen therapy, with personalised encoded mRNA, has demonstrated potential to enable patient’s immune system to target cells that cause cancer. Melanoma patients were treated with both mRNA-4157 (V940) and the immune checkpoint inhibitor pembrolizumab.
STAT
JUNE 10, 2024
Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses.
STAT
OCTOBER 13, 2023
As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.
Hospital Pharmacy Europe
JULY 11, 2024
In a letter published in The Lancet , researchers from the University of Birmingham highlighted the ‘concerning gap’ in measles immunity among healthcare workers in the UK, with as many as one in five not fully immunised against the infection. In both cohorts, the researchers found that measles immunity is currently suboptimal.
Pharmacy Times
DECEMBER 13, 2023
Fractional COVID-19 dosing resulted in fewer adverse effects and costs while producing similar immune responses compared to a full dose vaccine.
Pharmafile
APRIL 11, 2024
Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share, totaling an approximate $4.9bn. Alpine’s lead […] The post Vertex to acquire Alpine Immune Sciences for $4.9bn appeared first on Pharmafile.
STAT
OCTOBER 6, 2023
If the Covid-19 pandemic has shown us one thing, it is how little we really know about how the human immune system works. Decoding and harnessing the power of the human immune system is one of the great frontiers of biomedicine.
Pharmacy Times
JUNE 25, 2024
Pharmacies can position themselves as leaders in immunization services.
Pharmacy Times
JUNE 13, 2023
Pharmacists who immunize must ensure their knowledge about routine vaccinations for adults and children is up-to-date by reviewing the changes to the immunization schedule each year.
Pharmacy Times
JULY 22, 2022
Privigen is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients 15 years of age and older, chronic inflammatory demyelinating polyneuropathy in adults.
Hospital Pharmacy Europe
JULY 11, 2024
In a letter published in The Lancet , researchers from the University of Birmingham highlighted the ‘concerning gap’ in measles immunity among healthcare workers in the UK, with as many as one in five not fully immunised against the infection. In both cohorts, the researchers found that measles immunity is currently suboptimal.
STAT
MARCH 28, 2024
For scientists who study the human immune system, the penny dropped at different points in the early frenetic months of the Covid-19 pandemic. Looking back now, many marvel at the realization that they witnessed and were able to chronicle something no other scientists had ever actually seen.
Drug Store News
DECEMBER 1, 2022
Immune Booster features PreforPro, a probiotic that looks to help balance the gut microbiota, the company said.
STAT
FEBRUARY 28, 2024
The ads, which tell parents to contact their general practitioners if they’ve missed getting their kids immunized, are designed to capture parents’ desires to keep kids safe. Read the rest…
Pharmacy Times
OCTOBER 11, 2022
Study data showed that more than three-quarters of patients with dermatomyositis who received intravenous immune globulin therapy experienced improved symptoms.
European Pharmaceutical Review
OCTOBER 20, 2022
Recognising the potential of CAR T cells to act as highly targeted therapeutics, several biotechnology companies – including Sangamo Therapeutics – have established development pipelines of CAR T regulatory cells (Tregs) that aim to tackle immune?mediated What are Tregs and how are they applicable to immune-mediated disease?
STAT
MAY 21, 2024
Checkpoint inhibitors, drugs that unleash the immune system, have turned into blockbuster therapies that have transformed outcomes for some patients with deadly cancers.
Pharmacy Times
JUNE 17, 2023
For squamous cell carcinoma systemic therapy that is not concurrent with radiation therapy, preferred regimens are immune checkpoint inhibitors.
pharmaphorum
JANUARY 22, 2024
End of the line for Roche’s 18-year alliance with Swiss biotech AC Immune, as it returns rights to Alzheimer's antibodies crenezumab and semorinemab
Pharmacy Times
AUGUST 4, 2023
CDC Advisory Committee on Immunization Practices voted 10 to 0 to recommend the routine use of nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants.
Pharmacy Times
JANUARY 22, 2024
Infection-induced immunity with 2-dose vaccination still offered protection against the circulating variant.
Pharmacy Times
JUNE 3, 2023
Fecal microbiota transplant from responders to non-responders was able to rescue immune checkpoint inhibition use in patients with melanoma, with 40% of patients showing clinical benefit.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content